Hematology
From the Journals
Global blood supply runs low
Worldwide, more than 60% of countries had an inadequate supply of blood to meet the demand for transfusion.
Feature
Readmission burden high for those with sickle cell disease
SCD more than doubles the risk of 30-day readmission, compared with non-SCD stays.
From the Journals
Monthly and twice monthly emicizumab dosing safe for children with severe hemophilia A
The small study confirms the safety of twice-monthly or monthly emicizumab administration for children with severe hemophilia A without inhibitors...
Feature
Ongoing research aims to improve transplant outcomes in sickle cell
Over the past 2 years, the majority of novel transplant techniques have been primarily aimed at improving conditioning regimens and lowering rates...
Guidelines
ACOG advises bleeding disorder screening for teens with heavy menstruation
Bleeding disorders are found in approximately 20% of adolescent girls who present for evaluation of heavy menstrual bleeding and in 33% of...
From the Journals
Timing, volume of transfusion may not matter in children with severe anemia
The TRACT trial showed no significant differences in 28-day mortality or other clinical outcomes by transfusion timing or volume.
From the Journals
BRCA2 mutations linked to childhood NHL
Survivors of childhood non-Hodgkin may be at significantly increased risk for breast, ovarian, prostate, and other BRCA2-associated cancers.
Conference Coverage
Insurance-related barriers impede L-glutamine access
FORT LAUDERDALE, FLA. – Just one in five patients prescribed L-glutamine were still taking the drug after 10 months, according to a new real-world...
Conference Coverage
Oral voxelotor improves hemoglobin in sickle cell disease
AMSTERDAM – The investigational agent may have disease modifying effects, researchers reported.
Conference Coverage
QOL concerns prompt second-line therapy in children with ITP
NEW ORLEANS – Quality of life was the most common reason for starting second-line therapy in a cohort of children with immune thrombocytopenia.
Conference Coverage
Master trial seeks to aid drug development for pediatric AML
NEW ORLEANS – “What we see in childhood AML is a lot different than what we see in adult AML, and this challenges the paradigm that we have...